Apr 1, 2024, 12:55
Nicholas Sarlis: Dr Luis Raez succinctly describes recently reported results from key clinical trials in NSCLC patients
Nicholas Sarlis, Chief Medical Officer at CLEARA Biotech BV, shared a post on LinkedIn:
“Dr. Luis E Raez, a renowned lung cancer expert and eminent ex-collaborator, succinctly describes recently reported results from key clinical trials in NSCLC patients, namely PAPILLON, CHECKMATE 77T, and KEYNOTE-671. The VuMedi video below also provides the meaning of these recent NSCLC updates along with their ‘positioning’ across a complex and rapidly evolving therapeutic landscape.”
Proceed to the video.
Source: Nicholas Sarlis/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 13:46
Dec 21, 2024, 13:40
Dec 21, 2024, 13:33
Dec 21, 2024, 13:20
Dec 21, 2024, 13:12